直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

New Tesla Stipulation Pilots Petitioner Through Finitv's Choppy Waters

July 8, 2025

Authored and Edited by Umber Aggarwal; Forrest A. Jones; Joshua Everetts*

As Acting USPTO Director Coke Morgan Stewart (“Director”) continues to issue discretionary denial decisions, practitioners can benefit from practical insights offered by the Director’s recent decisions applying the USPTO’s updated Fintiv guidance. Two decisions—both involving Tesla, Inc. (“Tesla”) as Petitioner—provide instances in which the Director did not discretionarily deny institution for two primary reasons: Tesla’s broad “Sotera+” stipulation, and the complexity of the district court case.

Tesla v. Intellectual Ventures

Tesla initiated IPR proceedings challenging six Intellectual Ventures II LLC (“Intellectual Ventures”) patents asserted against it in one district court litigation.[1] The Acting Director denied Patent Owner's discretionary denial request despite finding many considerations favoring denial—including a “scheduled trial date [that] precedes the projected final written decision due date,” “insufficient evidence the district court is likely to stay its proceeding even if the Board were to institute trial,” and “meaningful investment in the parallel proceeding by the parties.” As detailed below, the denial was nevertheless bolstered by additional considerations that consisted of Tesla’s “broad stipulation,” strong “merits” based on previous Board findings, and “complex and diverse” parallel litigation proceedings.

First, it is common for Petitioners to file stipulations in a district court agreeing to not assert certain arguments. For example, a Sotera stipulation is one type that prevents a petitioner from raising in district court “any ground raised or that could have been reasonably raised in an IPR.”[2] Stipulations are considered in the Fintiv analysis, such as through the fourth Fintiv factor about the “overlap between issues raised in the petition and in the parallel proceeding.”[3]

Tesla’s “broad stipulation,” agreed to waive three categories of prior art grounds:

[I]f the PTAB institutes an IPR (and does not subsequently vacate institution) in response to Defendant’s petition against Plaintiff’s U.S. Patent No. 10,952,153 (IPR2025-00217), Defendant will not pursue in this litigation against the claims challenged in IPR2025-00217, (i) the specific grounds raised in IPR2025-00217, (ii) any other grounds that could have reasonably been raised before the PTAB in that instituted proceeding (i.e., any ground that could have reasonably been raised under §§ 102 or 103 on the basis of prior art patents or printed publications), or (iii) any ground based on a combination of system prior art and the references asserted as part of a ground raised in IPR2025-00217, as reflected in the table summarizing the Statutory Grounds for Challenges on page 16 of the Petition.[4]

Unlike a typical Sotera stipulation, Tesla’s “broad stipulation” had an additional provision that promised not to raise “any ground based on a combination of system prior art and the references asserted as part of a ground raised.”

Second, with respect to the “merits” favoring institution, the Director determined “that the merits are strong” because the Board’s previous determinations related to an “ancestor patent.” Specifically, the Director highlighted that the Board, in three separate proceedings, “previously determined there was a reasonable likelihood that similar claims of [the] ancestor patent were unpatentable.”

Third, the Director looked toward the “complexity and diversity” of the parallel litigation and found it “tip[ped] the balance against discretionary denial.” The litigation involved “eleven patents spanning nine different families that involve a diverse range of subject matter.” Due to the “large number and vast scope of the patents asserted in the district court litigation,” the Director found the Board to be “better situated to review” the patents-at-issue.

Tesla v. United States

On the same day, the Director denied another of Intellectual Ventures’ requests for discretionary denial of a different Tesla IPR.[5] This decision found the same factors to weigh for denial—a trial date that precedes a final written decision deadline, “insufficient evidence” for litigation stay, and “meaningful investment” in the parallel proceedings. However, this decision only discussed two factors that undermined discretionary denial: Tesla’s “broad stipulation” and “complex and diverse” parallel litigation.

Tesla relied on the same stipulation for this IPR as the one discussed for the first decision above.[6] Additionally, the complex parallel litigation is the same litigation as the one noted for the first set of IPRs. However, the Director did not provide any discussion of the merits in this decision.

Takeaways

To avoid discretionary denial, Petitioners should consider filing broad stipulations with scope going beyond Sotera stipulations and emphasizing any complexity of the parallel litigations, including the number of patents involved and the diverse scope of the patents overall. These factors can counsel in favor of institution even if other factors support denial. Petitioners should also examine PTAB decisions challenging related patents and determine whether those findings may be leveraged to show strong merits favoring intuition.

Patent Owners, on the other hand, should consider identifying the lack of broad stipulations or the simplicity of a case in requests for discretionary denial.


[1] Tesla, Inc. v. Intellectual Ventures II, Inc., IPR2025-00217, Paper 2 (PTAB Nov. 26, 2024); Tesla, Inc. v. Intellectual Ventures II, Inc., IPR2025-00219, Paper 2 (PTAB Nov. 26, 2024); Tesla, Inc. v. Intellectual Ventures II, Inc., IPR2025-00220, Paper 2 (PTAB Nov. 25, 2024); Tesla, Inc. v. Intellectual Ventures II, Inc., IPR2025-00221, Paper 2 (PTAB Nov. 25, 2024); Tesla, Inc. v. Intellectual Ventures II, Inc., IPR2025-00222, Paper 2 (PTAB Nov. 26, 2024); Tesla, Inc. v. Intellectual Ventures II, Inc., PR2025-00339, Paper 2 (PTAB Dec. 30, 2024).

[2] Sotera Wireless, Inc., v. Masimo Corp., IPR2020-01019, Paper 12 at 13-14 (PTAB Dec. 1, 2020).

[3] Apple Inc. v. Fintiv, Inc., IPR2020-00019, Paper 15 at 14 (PTAB May 13, 2020).

[4] See, e.g., Intellectual Ventures II, IPR2025-00217, Paper 8 at Ex. 1067, 2 (May 27, 2025).

[5] Tesla, Inc. v. United States, IPR2025-00341, Paper 12 (PTAB Jun. 13, 2025). In this Petition, The United States of America as Represented by the Secretary of the Navy (“US Navy”) and Intellectual Ventures II LLC were collectively Patent Owner because The US Navy was the assignee to the challenged patent and Intellectual Ventures was the exclusive licensee having all substantial rights. Id. at 2 n.1.

[6] United States, Paper 10 at Ex. 1032, 5.

Tags

Patent Trial and Appeal Board (PTAB), Fintiv, discretionary denials

Related Practices

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Related Industries

AI, Electronics, and Information Technology

Electrical and Computer Technology

Transportation and Logistics

Automotive and Smart Mobility Tech

Related Offices

Washington, DC

Contacts

Umber Aggarwal
Associate
Reston, VA
+1 571 203 2423
Email
Forrest A. Jones
Partner
Washington, DC
+1 202 408 4019
Email

*Joshua Everetts is a Summer Associate at Finnegan.

Copyright © 2025 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

Georgia Life Sciences Summit 2026

August 25-26, 2026

Sandy Springs

Lecture

IPIC/McGill Summer IP Course 2026: Understanding Trademarks

July 14, 2026

Montreal

Charitable

Bridges From School to Work Gala 2026

June 22, 2026

Washington, DC

Lecture

Munich Licensing Summer Course 2026

June 18-19, 2026

Munich

Conference

2026 Copyright Society Annual Meeting

June 14-16, 2026

Louisville

Articles

California Reaches Record $12.75 Million CCPA Settlement with General Motors Over Driver Data

June 4, 2026

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP